TBD | The AstraZeneca Saga

Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.  By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout? Guest:    Peter Aldhous, science reporter at Buzzfeed News Host Lizzie O’Leary   Learn more about your ad choices. Visit megaphone.fm/adchoices

Om Podcasten

The problem with the news right now? It’s everywhere. And each day, it can feel like we’re all just mindlessly scrolling. It’s why we created What Next. This short daily show is here to help you make sense of things. When the news feels overwhelming, we’re here to help you answer: What next? Look for new episodes every weekday morning.